KYTRIL

This brand name is authorized in Austria, Australia, Brazil, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Italy, Japan, Mexico, Netherlands, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug KYTRIL contains one active pharmaceutical ingredient (API):

1 Granisetron UNII 318F6L70J8 - GRANISETRON HYDROCHLORIDE

Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy. Read about Granisetron

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A04AA02	Granisetron	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5898K, 5899L, 8728J, 8729K, 8730L, 8873B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529202802159317, 529202803155315, 559118080008617, 559118080008717
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.658-05-04, 28285-10-07
Country: EE	Ravimiamet	Identifier(s): 1023859, 1023950
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 59867, 60204, 61803
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 481447, 509680
Country: FR	Base de données publique des médicaments	Identifier(s): 63420868, 67592694, 69000764
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 147365, 40682, 47223
Country: HK	Department of Health Drug Office	Identifier(s): 36669, 44569, 61365
Country: IE	Health Products Regulatory Authority	Identifier(s): 30471, 30505
Country: IT	Agenzia del Farmaco	Identifier(s): 028093021, 028093084
Country: JP	医薬品医療機器総合機構	Identifier(s): 2391002C1037, 2391002F1025, 2391002F2021, 2391400A3024, 2391400A4020, 2391400G1130, 2391400G4023
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 307M96, 353M94
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 38857, 49492
Country: SG	Health Sciences Authority	Identifier(s): 07089P, 07800P, 13539P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699708011603, 8699708011610, 8699708011627, 8699708751714, 8699708751721
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/5.7.2/0162, 30/5.7.2/0346, 31/5.7.2/0082, Y/5.7.2/272